Viewing Study NCT02958969


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2026-02-11 @ 8:34 PM
Study NCT ID: NCT02958969
Status: COMPLETED
Last Update Posted: 2019-12-17
First Post: 2016-11-05
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Apixaban for Primary Prevention of Venous Thromboembolism in Patients With Multiple Myeloma
Sponsor: Gregory Piazza
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Venous Thromboembolism View
None Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None venous thromboembolism View
None multiple myeloma View
None anticoagulation View